Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors
Leukemia, 07/11/2012
Zhang X et al. – The findings suggest that E2A–HLF sensitizes t(17;19)–acute lymphoblastic leukemia (ALL) to the graft–versus–leukemia (GVL) effect by upregulating death receptors for Tumor necrosis factor–related apoptosis–inducing ligand (TRAIL).



